Cargando…
Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes
A recent death projection has placed pancreatic ductal adenocarcinoma as the second cause of death by cancer in 2030. The prognosis for pancreatic cancer is very poor and there is a great need for new treatments that can change this poor outcome. Developments of therapeutic innovations in combinatio...
Autores principales: | Rouanet, Marie, Lebrin, Marine, Gross, Fabian, Bournet, Barbara, Cordelier, Pierre, Buscail, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486054/ https://www.ncbi.nlm.nih.gov/pubmed/28594388 http://dx.doi.org/10.3390/ijms18061231 |
Ejemplares similares
-
Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach
por: Le Cosquer, Guillaume, et al.
Publicado: (2023) -
Salivary MicroRNA in Pancreatic Cancer Patients
por: Humeau, Marine, et al.
Publicado: (2015) -
Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy
por: Buscail, Louis, et al.
Publicado: (2022) -
Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer
por: Bournet, Barbara, et al.
Publicado: (2011) -
Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives
por: Buscail, Etienne, et al.
Publicado: (2021)